Entourage Health Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Entourage Health Corp from these most-recent analyst ratings.
Buy Now | Get Alert | ||||||||
---|---|---|---|---|---|---|---|---|---|
No data available to display |
There is no price target for Entourage Health
There is no analyst for Entourage Health
There is no last upgrade for Entourage Health
There is no last downgrade for Entourage Health.
There is no next analyst rating for Entourage Health.
There is no next analyst rating for Entourage Health.
Browse analyst ratings and price targets on all stocks.